UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): 05/01/2008
ACADIA Pharmaceuticals Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 000-50768
Delaware | | 06-1376651 |
(State or other jurisdiction of | | (IRS Employer |
incorporation) | | Identification No.) |
3911 Sorrento Valley Boulevard
San Diego, CA 92121
(Address of principal executive offices, including zip code)
(858) 558-2871
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(d) On May 1, 2008, our Board of Directors elected Laura A. Brege as a director to fill an existing vacancy. We are not aware of any item requiring disclosure under Item 404(a) of Regulation S-K.
Signature(s)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | ACADIA Pharmaceuticals Inc. |
| |
| |
| Date: May 02, 2008 | | | | By: | | /s/ Thomas H. Aasen
|
| | | | | | | | | Thomas H. Aasen |
| | | | | | | | | Vice President, Chief Financial Officer, Treasurer and Secretary |
| |
| |
